Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
01/2004
01/14/2004CN1468232A Heterocyclic sodium/proton exchange inhibitors and method
01/14/2004CN1468227A Non-imidazole aryloxyalkylamines
01/14/2004CN1468221A Non-imidazole aryloxypiperidines
01/14/2004CN1468214A Novel derivatives of aminocyclohexane
01/14/2004CN1468211A Nitroso diphenylamine derivatives
01/14/2004CN1468209A Stable salts of o-acetylsalicyclic with basic amino acids
01/14/2004CN1468207A New retinoids for the treatment of emphysema
01/14/2004CN1134421C Antifungal and its preparation method and intermediate
01/14/2004CN1134410C Amine derivative, process for producing same, and use thereof as antiarrhythmic medicine
01/13/2004US6677487 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base
01/13/2004US6677459 Amino acid derivatives and methods of making the same
01/13/2004US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists
01/13/2004US6677308 Integrin antagonists; antitumor, antimetastasis, anticarcinogenic agents; angiogenesis and restenosis inhibitors; osteoporosis
01/08/2004WO2004002977A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2003093302A3 Process for the synthesis of peptides amides by side-chain attachement to a solid phase
01/08/2004WO2003077828A3 Novel florfenicol-type antibiotics
01/08/2004US20040006224 Synthesis of 2-alkyl amino acids
01/08/2004US20040006120 Administering to a patient in need of such weight loss or treatment an effective amount of an inverse agonist of histamine H3 receptors, with the proviso that inverse agonist is not thioperamide
01/08/2004US20040006098 Induce cytokine biosynthesis in animals
01/08/2004US20040006087 Method of treating cancer using FPT inhibitors and antineoplastic agents
01/08/2004US20040006085 For therapy and prophylaxis of neurological disorders associated with beta -amyloid peptide; Alzheimer's disease
01/08/2004CA2489433A1 Inhibitors of hcv ns5b polymerase
01/07/2004EP1378544A2 Tetraaza-pentamethine derivatives and their application for dyeing keratinous fibres
01/07/2004EP1378507A2 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same
01/07/2004EP1378230A1 Para-phenylenediamine derivatives comprising a pyrrolidinyl group substituted by a cyclic radical and their use in colouring keratinic fibres
01/07/2004EP1377601A2 Type b botulism toxin inhibitors
01/07/2004EP1377557A1 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor
01/07/2004EP1377295A2 Carboxamide derivatives as therapeutic agents
01/07/2004EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
01/07/2004EP1377263A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye
01/07/2004EP1377262A1 Dyeing composition for dyeing keratinous fibres comprising a cationic azo-dye
01/07/2004EP1103243B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives for the treatment of troubles mediated by an excess of substance p
01/07/2004EP0748315B1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, these products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same
01/07/2004CN1466582A Substituted aryl ketones and their use as herbicides
01/07/2004CN1466572A 吡咯衍生物 Azole derivatives
01/07/2004CN1466419A Stabilized compositions having antibacterial activity
01/07/2004CN1133647C Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist
01/07/2004CN1133623C Process for producing optically active imidazole compound, intermediates for synthesizing samke and mfg method
01/06/2004US6673942 Resolution of DL-racemic mixtures
01/06/2004US6673941 Disubstituted imidazoles useful in the treatment of bacterial infections
01/06/2004US6673927 Farnesyl transferase inhibitors
01/06/2004US6673821 Nitrogen heterocycle inhibitors of aspartyl protease
01/06/2004US6673804 Preventing or treating arthritis (particularly osteoarthritis) or inhibiting metastasis, invasion or growth of cancer (particularly breast cancer)
01/06/2004US6673799 Inhibits binding to androgen receptor; antiandrogen
01/06/2004US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
01/06/2004US6673257 Blends employing at least two organic compounds having known melt temperatures, exhibit improved thermal properties and performance characteristics
01/02/2004EP1375611A2 Colored particle dispersion, ink jet ink, dye, and ink jet recording method
01/02/2004EP1375545A1 Catalyst and process for the trimerisation of isocyanates
01/02/2004EP1373249A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
01/02/2004EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2004EP1373219A1 Thiohydantoins and use thereof for treating diabetes
01/02/2004EP1373218A1 Imidazolyl derivatives useful as histamine h3 receptor ligands
01/02/2004EP1373217A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
01/02/2004EP1373194A1 BENZAMIDE INHIBITORS OF FACTOR Xa
01/02/2004EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals
01/02/2004EP1373185A2 Hydrophobic polyamine analogs and methods for their use
01/02/2004EP1372844A1 High activity metal carbene metathesis catalysts generated using a thermally activated n-heterocyclic carbene precursor
01/02/2004EP1372655A2 Cathepsin cysteine protease inhibitors
01/02/2004EP1372615A1 Compounds and compositions for delivering active agents
01/02/2004EP1140819B1 Alfa-sulfenimino acid derivatives
01/02/2004EP1027339B1 Method and reagents for n-alkylating ureides
01/01/2004US20040002613 Synthesis of benzonitriles from substituted benzoic acid
01/01/2004US20040002608 Central nervous system disorders
01/01/2004US20040002599 Substituted benzoycyclohexenones
01/01/2004US20040002525 Obesity; osteoporosis
01/01/2004US20040002506 Antiproliferative agents; antitumor agents
01/01/2004US20040002491 Melatonergic receptors
01/01/2004US20040002490 Melatonergic receptors
01/01/2004US20040002463 Inhibitors and methods of use thereof
12/2003
12/31/2003WO2004001059A2 Heterocyclic inhibitors of kinases
12/31/2003WO2004000856A1 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
12/31/2003WO2004000855A1 Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd
12/31/2003WO2004000797A1 Alpha-sulfonylamino-acetonitriles
12/31/2003WO2004000779A1 Process for producing phenyloxocarboxylic ester derivative
12/31/2003WO2004000295A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003WO2003063576A3 Arylsulfonamidobenzylic compounds
12/31/2003CN1132819C 作为TNF-α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CN1132815C 杂芳香族醛类的制造方法 The method of manufacturing the heteroaromatic aldehyde
12/31/2003CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670393 Carbamate-based cationic lipids
12/30/2003US6670387 Thrombocytopenia; hydroxy-1-azo-naphthalene derivatives; 3-hydroxy-4-((2-hydroxy-1-naphthalenyl)azo-)-1-naphthalenesul fonic acid; promoters of thrombopoiesis and megakaryocytopoi esis; enhancing platelet production; agonizing TPO receptor
12/30/2003US6670358 Substituted thioacetamides
12/30/2003US6670344 Having greater solubility than native combretastatin A-4, and rapidly regenerate combretastatin A-4 under physiological conditions; for use in cancer therapy
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2198637C Preparation of quaternized glycine nitriles
12/30/2003CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia
12/25/2003WO2003106572A1 Printing process using specified azo compounds
12/25/2003WO2003105853A1 1-aryl-4-substituted piperazines derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
12/25/2003US20030236438 Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts
12/25/2003US20030236435 Synthesis of 2-alkylcysteine via substituted thiazoline ester
12/25/2003US20030236434 Condensing cysteine with cabocyclic nitriles to form 2-arylthiazoline-4-carboxylic acid, then amidation, alkylation, hydrolyzing and optionally purifying to form 2-methylcysteine
12/25/2003US20030236426 Synthesis of benzimidate from benzoic acid
12/25/2003US20030236420 Pharmaceuticals
12/25/2003US20030236415 Etherifying mucochloric or mucobromic acid with an alcohol, alkylation, hydrogenation, dehydrochlorination or dehydrobromination, decyclization by reductive amination and carboxylation; 3-Aminomethyl-5-methyl-hexanoic acid
12/25/2003US20030236413 Catalysis in presence of a metallic element, an imine ligand and nitrogen compound as chelating compound, forming a chemical intermediates in the agrochemical and pharmaceutical fields
12/25/2003US20030236404 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/25/2003US20030236287 Central nervous system disorders; analgesics; antiinflammatory agents; cognition activators; anticancer agents; antidiabetic agents
12/25/2003US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
12/25/2003US20030236274 Naphthalene derivatives, their production and use